Ambu A/S | Income Statement

Fiscal year is October-September. All values DKK Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,383
1,584
1,889
2,084
2,355
2,606
Cost of Goods Sold (COGS) incl. D&A
747
843
1,036
1,029
1,098
1,111
Gross Income
636
741
853
1,055
1,257
1,495
SG&A Expense
474
539
612
697
796
932
EBIT
158
198
241
358
461
563
Unusual Expense
61
15
15
4
2
64
Non Operating Income/Expense
7
25
18
2
36
2
Interest Expense
20
38
29
30
34
36
Pretax Income
70
208
215
326
393
465
Income Tax
22
57
63
76
92
128
Consolidated Net Income
48
151
152
250
301
337
Net Income
48
151
152
250
301
337
Net Income After Extraordinaries
48
151
152
250
301
337
Net Income Available to Common
48
151
152
250
301
337
EPS (Basic)
0.21
0.64
0.63
1.05
1.27
1.39
Basic Shares Outstanding
234
237
240
237
237
243
EPS (Diluted)
0.20
0.62
0.61
1.02
1.24
1.36
Diluted Shares Outstanding
234
242
247
244
243
248
EBITDA
232
286
337
458
565
678
Other Operating Expense
4
4
-
-
-
-
Non-Operating Interest Income
-
8
-
-
-
-

About Ambu A/S

View Profile
Address
Baltorpbakken 13
Ballerup CR 2750
Denmark
Employees -
Website http://www.ambu.com
Updated 07/08/2019
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope.